sk&f-38393 has been researched along with Amentia in 2 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sheng, G | 1 |
Zhang, J | 1 |
Gao, S | 1 |
Gu, Y | 1 |
Jiang, B | 1 |
Gao, Q | 1 |
Torack, RM | 1 |
Miller, JW | 1 |
Roth, KA | 1 |
2 other studies available for sk&f-38393 and Amentia
Article | Year |
---|---|
SKF83959 Has Protective Effects in the Scopolamine Model of Dementia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amnesia; Animals; Avoidance Learning; Br | 2018 |
Deafferentation-induced abnormal neurofilament phosphorylation in red nucleus neurones.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Afferent Pathways; Animals; Benzazepines | 2001 |